Labiotech.eu

News and Trends 30 Apr 2015

A new Microfluidic Chip technology raised €1.9Million

Lunaphore Technologies closed a Series A financing round of €1.9M (CHF 2 millions). The round was led by Redalpine Venture Partners in Zurich with the participation of private investors from Switzerland and the United Kingdom. Lunaphore’s young team wants to use this cash to develop its first tissue diagnostics platform. The young Swiss medtech company, […]

April 30, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 29 Apr 2015

Biocartis shakes Euronext with an IPO that raised €100M

Last Monday, Belgian Biocartis launched an IPO that quickly raised €100M; the offering was closed a week ahead of schedule. The unquestionable interest of the investors, both in Belgium and internationally, shows the company’s potential and the appeal of its technology. The company, which raised €64.5M in September in a private financial round, intends to […]

April 29, 2015 - 1 minutemin - By Lourdes Riquelme

News and Trends 29 Apr 2015

Cytena greets €1.1M of Seed Capital

Cytena and its cy-Clone device to separate single cells received €1.1M from a consortium made up of a private investor and the High-Tech Gründerfonds (HTGF). Cytena will use this capital injection primarily to launch its product and to expand its marketing and distribution activities. The cy-Clone, cytena’s newest innovation, is a laboratory device that enables the […]

April 29, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 29 Apr 2015

European GMOs: which side are you on?

Last week, the European Commission approved 19 GMOs, the first authorizations since 2013. Shortly after, different reactions showed up, with some people more willing to celebrate than others. While GMOs are widely grown in America and Asia, Europe is still reluctant to this new technology. These authorizations came after a year of European blockage. But […]

April 29, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 29 Apr 2015

Giant Baupost Group bets on Biotie

Finland-based Biotie Therapies will receive an investment of more than €92M from Baupost group. However, the investment is conditional and linked to the result of the appointment of a new board member expected for the 26th of May. Seth Klarman’s billionaire Baupost group will back Biotie on its way to develop tozadenant, its lead product candidate. The […]

April 29, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 28 Apr 2015

PEP-Therapy Raised €1.3 Million in Seed Capital

France-based PEP-Therapy has raised €1.3M in initial funding. This sum, invested by the Quadrivium 1 seed fund and a business angel, Dr Bernard Majoie, will enable the cancer-focused company to undertake regulatory development of its first therapeutic product, a biomarker. The biomarker works as a predictive for foreseeing the effectiveness of a cancer treatment. The […]

April 28, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 28 Apr 2015

Will 2015 be the year of biosimilars?

The Biosimilar drug field is growing fast despite the tight regulatory, business and financial challenges it faces. The industry is forecasted to be worth up to €23Bn by 2020. To explore the market opportunities for biosimilars, it is necessary to be aware of all the latest news and to stand at the forefront of the current landscape […]

April 28, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 27 Apr 2015

Ynsect: what’s behind this Yellow Biotech champion?

How do you manage a planet with a growing population with increasing consumption needs when you only have a limited amount of ressources available? Everybody knows it’s a never-ending debate, but some companies are grabbing their chance to change the world. Ynsect is one of the many firms trying to do so, and could be a future champion of the Yellow Biotech […]

April 27, 2015 - 5 minutesmins - By Joachim Eeckhout

News and Trends 25 Apr 2015

Desktop Genetics launches a new Gene Editing Platform

Desktop Genetics has just launched the DeskGen Platform for gene editing. It combines elements of the Company’s earlier tools, and allows researchers to design genome editing vectors and cloning strategies optimized to their own laboratories and experimental needs. The DeskGen platform gives life scientists the power to expertly design optimized genome editing experiments in any cell […]

April 25, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 24 Apr 2015

Novo Nordisk Takes on One of the World’s Biggest Markets: Obesity

Novo Nordisk, the Danish global healthcare company, received the all clear a few month ago from the US, EU and Canada to launch and sell a new treatment for Weight Management, Saxenda. The company announced the launch of Saxenda in the US, who present the treatment as an adjunct to a reduced-calorie diet and increased physical activity for chronic […]

April 24, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 24 Apr 2015

Interview with Dr. Andrei Popov, CEO at Ecrins Therapeutics

Dr. Andrei Popov, CEO at Ecrins Therapeutics Photo credit: Ecrins Therapeutics Laureate of the 2002 INSERM program “Avenir”, Dr. Andrei Popov launched a research project with a focus on the mechanisms of cell division and bioactive small molecules, both fields relevant to oncology (INSERM and Joseph Fourier University in Grenoble). The discovery of several drug […]

April 24, 2015 - 5 minutesmins - By Marie Godar

News and Trends 23 Apr 2015

Are personalized treatments for lung cancer underutilized?

Results from a new global survey of lung cancer oncologists have shown that, despite 81% of newly diagnosed advanced non-small cell lung cancer (NSCLC) patients being tested for Epidermal Growth Factor Receptor mutations (EGFR), a significant number of those tested were not receiving personalized treatments for their cancer type and mutation subtype. The survey, with […]

April 23, 2015 - 3 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

A new Microfluidic Chip technology raised €1.9Million

Biocartis shakes Euronext with an IPO that raised €100M

Cytena greets €1.1M of Seed Capital

European GMOs: which side are you on?

Giant Baupost Group bets on Biotie

PEP-Therapy Raised €1.3 Million in Seed Capital

Will 2015 be the year of biosimilars?

Ynsect: what’s behind this Yellow Biotech champion?

Desktop Genetics launches a new Gene Editing Platform

Novo Nordisk Takes on One of the World’s Biggest Markets: Obesity

Interview with Dr. Andrei Popov, CEO at Ecrins Therapeutics

Are personalized treatments for lung cancer underutilized?

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!